Elite Pharmaceuticals, Inc. Finite-lived Intangible Assets Acquired
Elite Pharmaceuticals, Inc. (ELTP) reported Finite-lived Intangible Assets Acquired of $900.00 thousand for the 12-month period ending 2025-03-31, per its 10-K filed 2026-06-29.
Financial Statements › Notes
us-gaap:FinitelivedIntangibleAssetsAcquired1 · last filed 2026-06-29
- Elite Pharmaceuticals, Inc. finite-lived intangible assets acquired for the quarter ending 2025-03-31 was $0.00.
- Elite Pharmaceuticals, Inc. finite-lived intangible assets acquired for the quarter ending 2024-12-31 was $0.00.
- Elite Pharmaceuticals, Inc. finite-lived intangible assets acquired for the quarter ending 2024-09-30 was $0.00.
- Elite Pharmaceuticals, Inc. finite-lived intangible assets acquired for the quarter ending 2024-06-30 was $900.00K.
- Elite Pharmaceuticals, Inc. finite-lived intangible assets acquired for fiscal 2025 was $900.00K.
- Elite Pharmaceuticals, Inc. finite-lived intangible assets acquired for fiscal 2023 was $0.00.
- Elite Pharmaceuticals, Inc. finite-lived intangible assets acquired for fiscal 2016 was $30.02K, a 5.74% decline from fiscal 2015.
- Elite Pharmaceuticals, Inc. finite-lived intangible assets acquired for fiscal 2015 was $31.86K, a 99.44% decline from fiscal 2014.
| Period end | Finite-lived Intangible Assets Acquired 3 month | Finite-lived Intangible Assets Acquired 6 month | Finite-lived Intangible Assets Acquired 9 month | Finite-lived Intangible Assets Acquired 12 month | Finite-lived Intangible Assets Acquired 12 month as first filed |
|---|---|---|---|---|---|
| 2025-03-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-06-29 | $0.00 derived: sum of 2 quarters · filed 2026-06-29 | $0.00 derived: sum of 3 quarters · filed 2026-06-29 | $900.00K 10-K · filed 2026-06-29 | |
| 2024-12-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-02-13 | $0.00 derived: sum of 2 quarters · filed 2025-02-13 | $900.00K 10-Q · filed 2025-02-13 | ||
| 2024-09-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-11-14 | $900.00K 10-Q · filed 2024-11-14 | |||
| 2024-06-30 | $900.00K 10-Q · filed 2024-08-14 | ||||
| 2024-03-31 | $0.00 10-Q · filed 2025-02-13 | ||||
| 2023-03-31 | $0.00 10-K · filed 2024-07-01 | ||||
| 2016-03-31 | $3.87K derived: 10-K 12 month − 10-Q 9 month · filed 2016-06-15 | $12.13K derived: sum of 2 quarters · filed 2016-06-15 | $30.02K 10-K · filed 2016-06-15 | ||
| 2015-12-31 | $8.27K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-02-09 | $26.16K 10-Q · filed 2016-02-09 | |||
| 2015-09-30 | $17.89K 10-Q · filed 2015-12-30 | ||||
| 2015-03-31 | $31.86K 10-K · filed 2016-06-15 | $31.85K 10-K · filed 2015-06-15 | |||
| 2014-03-31 | $5.66M 10-K · filed 2015-06-15 |